Canna Law Blog

APRIL 13, 2019

These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. For a complete list of questions and topics identified by the FDA, see here. Specifically, the agency fears that.

CBD 90

CBD Safety Topical Food 90

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. With enrollment completed, treatment is expected to conclude towards the end of March and results are anticipated to be announced in the second half of calendar 2020.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

SEPTEMBER 29, 2021

With patient safety at the center of its mission, TCI was created to educate healthcare professionals on the risks and benefits of medical cannabis, now legal in the state of New York and beyond. About The Cannabinoid Institute ??

Cannabinoids 52

Cannabinoids Education Patients Safety 52

Cannabis Law Report

JUNE 3, 2022

atai Life Sciences is a biopharmaceutical company focused on developing novel treatments for mental health disorders so that everyone, everywhere can live a more fulfilled life. technology, clinical protocol, human-interaction psychology, and data science? work on a wide range of topics?? . at atai (View all jobs).

Environment 52

Environment Topical Data Safety 52

Cannabis Law Report

MARCH 1, 2022

atai Life Sciences is a biopharmaceutical company focused on developing novel treatments for mental health disorders so that everyone, everywhere can live a more fulfilled life. technology, clinical protocol, human-interaction psychology, and data science? work on a wide range of topics?? . at atai (View all jobs).

Environment 40

Environment Topical Data Safety 40

The Blunt Truth

AUGUST 13, 2019

On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The FDA is collecting data to fill these gaps. The public hearing attracted over 100 speakers and 2000 participants.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. With enrollment completed, treatment is expected to conclude towards the end of March and results are anticipated to be announced in the second half of calendar 2020.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g., For Alzheimer’s patients, CBD is one treatment option that is slowing the progression of that disease.”.

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Law Report

DECEMBER 2, 2021

Below is a breakdown of the topics core training covers and the minimum hours students would devote to each subject: Historical, Traditional, and Contemporary Plant Medicine Practices and Applications (12 Hours). Safety, Ethics and Responsibilities of a Psilocybin Facilitator (10 Hours). Group Psilocybin Facilitation (8 Hours).

Law 52

Law Programs Therapy Education 52

The Cannigma

AUGUST 24, 2021

The Jointly database includes a very comprehensive assortment of flower stains, edibles, concentrates, tinctures, and topicals, and vows that “if it’s legal, we include it on our platform for the benefit of our community.”. The feedback is gathered and used to provide tailor made recommendations for products and doses. Learn More.

Seed-To-Sale 111

Seed-To-Sale Research and Development Data Strains 111

Cannabis Law Report

MARCH 19, 2020

2 At the conclusion of the meeting, FDA stated that it would form an internal working group to study data gaps relating to CBD. As indicated by FDA’s recent announcement, the collection of data about the risks and benefits of CBD remains a priority for the agency. FDA submitted this report last week, as is discussed below.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

NORML

MAY 24, 2019

At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives.

Marijuana 103

Marijuana Education Advocacy Legislation 103

Veriheal

JANUARY 5, 2022

Despite the restrictions on research as a result of the Schedule I classification of cannabis, researchers have made many remarkable strides in proving the efficacy and safety of cannabis on the aforementioned conditions. . While Biden is receiving a lot of heat as a result of his inaction, many feel it is deserved.

Legislation 52

Legislation Cannabis Therapy Access 52

The Cannigma

JULY 3, 2023

Happily, the body of research into cannabis and psychedelics (including MDMA) is expanding fast, and it’s likely that better data on their interactions will become available in the near future. They found that it could be used in sessions to promote trust and safety, helping patients to open up and process traumatic experiences.

Research and Development 46

Research and Development Environment THC Microdosing 46

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). BMC Fam Pract.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In

THC 52

THC CBD Media Food 52

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 59

Marijuana Therapy Data THC 59

Cannabis Law Report

APRIL 12, 2019

Being of European descent it is a privilege to be updating Europe on such an exciting topic. We aim to continue to do more for the Canadian patients who choose to use medical cannabis as a treatment option. I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep.

Access 45

Access Patients Marijuana Medicine 45

CannaMD

DECEMBER 9, 2020

Little time will be devoted to opening sections which cover well-documented topics such as historic and current cannabis use, definitions, formulations, pharmacokinetics, pharmacodynamics, and policies on use. The authors also caution against the consumption of certain over-the-counter topical CBD products which do not fall under the U.S.

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Cannabis Law Report

OCTOBER 29, 2021

The primary endpoint of this Phase 1 trial was safety and tolerability. We expect to report this data as it becomes available and after submission to the FDA. in thousands, except share data). . . . in thousands, except loss per share and share data). . . million of net proceeds from the issuance of equity stock.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

JULY 24, 2019

321(g)(1), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or any function of the body. March 25, 2019 posting – “CBD is being adopted more and more as a natural alternative to pharmaceutical-grade treatments for depression and anxiety.”.

CBD 51

CBD Tincture Pets Chronic Pain 51

The Cannigma

JANUARY 13, 2023

Edibles won’t produce the same experience, but topicals may be able to help, too. The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” headaches per month.

Terpenes 132

Terpenes Strains THC Treatment 132

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. After treatment with CBD oil (max dose 75 mg twice daily), participants achieved significant reductions in pain.[4]. 1] Animal models, however, do not always translate to a human experience.

CBD 98

CBD Chronic Pain Oil Topical 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. doi: 10.1016/j.bjoms.2021.06.005.

CBD 144

CBD Seed-To-Sale Food Access 144

Canna Law Blog

JULY 25, 2022

Namely, how to prioritize safety and education amongst its youth. This topic also has been a large focus of these hearings. developments in this area, to further strengthen and develop health and social responses, such as prevention programs, treatment and harm reduction interventions and to find new. What about the UN?

Legalization 90

Legalization Marijuana Safety Policy 90

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. Eurofins Viracor launched COVID-19 inSIGHT™ T Cell immunity testing to provide healthcare providers with critical insight to aid treatment decisions. On 22 April 2021, Mr. Pascal Rakovsky was appointed as Lead Independent Director.

Business 105

Business Research and Development Environment Food 105

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. After treatment with CBD oil (max dose 75 mg twice daily), participants achieved significant reductions in pain.[4]. 1] Animal models, however, do not always translate to a human experience.

CBD 52

CBD Chronic Pain Oil Topical 52

Healer

APRIL 5, 2021

Store aisles are stocked full of CBD oils, capsules, and tablets, topicals such as lotions, balms, salves and creams, vape pens, and hemp flower. After treatment with CBD oil (max dose 75 mg twice daily), participants achieved significant reductions in pain.[4]. 1] Animal models, however, do not always translate to a human experience.

CBD 52

CBD Chronic Pain Oil Topical 52

Puff Puff Post

NOVEMBER 5, 2019

INM-755 is a single-cannabinoid topical cream under development for the treatment of symptoms associated with epidermolysis bullosa (“EB”). Two strengths of INM-755 cream will be evaluated in 22 adult subjects over a 14-day treatment period. Most types of epidermolysis bullosa are inherited. About INM-755.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

DECEMBER 22, 2019

The information came alongside the firm’s release of a for-purchase report on the topic. The firm cited data from the New Jersey Department of Health’s 2018 statistical report, where the patient count for medical cannabis was over 10,000 in 2016, and increased to around 24,000 in 2018. per cent over the 2019 – 2027 period. New Jersey.

Blood Pressure 59

Blood Pressure Concentrates Terpenes Medicine 59

Cannabis Law Report

DECEMBER 8, 2021

Single-dose transdermal delivery of Epoladerm was well-tolerated in all minipigs and no treatment-related clinical observations, changes in body weight, or dermal irritation were observed. This data should strengthen the Company’s IND filing in advance of the anticipated start of first-in-human clinical trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Otherside Farms

DECEMBER 10, 2019

CBD is additionally being investigated as an available treatment for pain, anxiety, and schizophrenic psychosis symptoms in humans. According to experts, CBD is used due to its healing properties, though there’s no conclusive data on this use. The safety and risks of CBD for dogs haven’t but been researched.

Oil 18

Oil CBD Pets Blood Pressure 18

The Cannigma

FEBRUARY 3, 2022

Ingestion, inhalation, et cetera, topical, transdermal. That’s always the struggle we have when people want data and research and medical research to establish exactly how something works. MB: Right and it was a safety consideration and it’s seemed like a good idea. MB: Of course. CP: At what dose.

Wellness and Beauty 109

Wellness and Beauty Patients Medicine Cannabis 109